Balloon aortic valvoplasty may serve as a viable alternative for selected high-risk patients with severe aortic stenosis and cardiogenic shock who have contraindications to AVR and TAVI.
May warrant consideration in select high-risk aortic stenosis shock cases; leaves open need for prospective validation.
The standard treatment of calcific aortic stenosis (AS) is aortic valve replacement (AVR). However, as population has become older, the number of patients who have prohibitive surgical risk is increasing. Although transcatheter aortic valve implantation (TAVI) has been indicated to some of these high-risk patients, its indication is limited because of anatomical contraindications, unstable clinical situations and financial problems. Thus, in experienced hands, the option for balloon aortic valvoplasty (BAV) should be considered, as it may be a good alternative to selected patients to ameliorate symptoms and prolong survival. In this report, we describe the case of an old patient with severe AS who evolved with cardiogenic shock and had contraindications to surgery and transcatheter valve implantation and who was successfully treated by BAV. J Med Cases. 2014;5(11):583-586 doi: http://dx.doi.org/10.14740/jmc1953e
No takes yet. Share an insight, caveat, or question.
Costa et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: